Skip to content
AnalystLens

Humana Quarterly Report for Q3 Ended Sep 30, 2026

Filing Date
Filed November 6, 2026
Period End
September 30, 2026
Security
HUM
In the record · 2016–202610-K1110-Q338-K200

HUM filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 200 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Aug ’19Aug ’19
  3. Leadership change8-K · Mar ’22Mar ’22
  4. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 10-Q filed November 6, 2026. Cited figures are marked; the original filing is the authoritative source.

Humana Inc. reported robust revenue growth for the nine months ended September 30, 2026, driven by a significant increase in premiums revenue, up 25.3%a year-over-year, largely due to expanded Medicare membership and higher per-member premiums.

Services revenue also saw substantial growth, increasing by 28.8%b, fueled by the CenterWell platform. While revenue expanded, the company experienced a notable increase in benefits expense, up 28.4% for the nine-month period, leading to a higher benefit ratio. This was attributed to increased Medicare Advantage membership, particularly with new members who tend to have higher benefit ratios, and lower favorable prior-period claims reserve development.

Despite these pressures, operating costs increased at a slower pace than revenue, resulting in improved operating cost ratios. The company's net income attributable to Humana remained relatively stable year-over-year for the nine months, at $2.04 billionc and $1.98 billion respectively, indicating effective management of expenses in the face of rising benefit costs.

Key Highlights

  1. Total revenues increased by 25.2% to $121.7 billion for the nine months ended September 30, 2026, compared to $97.1 billion in the prior year period.
  2. Premiums revenue saw a significant increase of 25.3% year-over-year, reaching $115.2 billion for the nine months ended September 30, 2026.
  3. Services revenue grew by 28.8% to $5.6 billion for the nine months ended September 30, 2026.
  4. Benefits expense increased by 28.4% to $105.4 billion for the nine months ended September 30, 2026, impacting the benefit ratio.
  5. Operating costs increased by 14.4% for the nine months ended September 30, 2026, growing at a slower rate than revenue.
  6. Net income attributable to Humana was $2.04 billion for the nine months ended September 30, 2026, a slight increase from $1.98 billion in the prior year period.
  7. The company acquired MaxHealth on February 13, 2026, for approximately $908 million, contributing to goodwill and intangible assets.

Financial Statements

Q3 FY2026 against Q3 FY2025

Line itemQ3 FY2026Q3 FY2025Change
Revenue$41.16B$32.65B+26.1%
SG&A Expenses$4.60B$4.08B+12.6%
Operating Income$75.00M$400.00M−81.2%
Net Income$162.00M$195.00M−16.9%
EPS (Basic)$1.35$1.62−16.7%
EPS (Diluted)$1.33$1.62−17.9%
Shares Outstanding (Basic)120.09M120.27M−0.1%
Shares Outstanding (Diluted)121.83M120.75M+0.9%

Frequently Asked Questions

  1. What was the primary driver of Humana's revenue growth in the nine months ended September 30, 2026?

    Humana's revenue growth was primarily driven by a significant increase in premiums revenue, up 25.3%, which was largely attributed to membership growth across its Medicare businesses and higher per-member premiums. Additionally, services revenue saw substantial growth of 28.8%, boosted by the expansion of the CenterWell platform.

  2. How did Humana's benefits expense trend in the period, and what was the impact on profitability?

    Benefits expense increased by 28.4% for the nine months ended September 30, 2026, outpacing the growth in premiums revenue. This led to a higher benefit ratio, indicating increased claims costs. While this pressured margins, operating costs grew at a slower pace, helping to partially offset the impact on overall profitability.

  3. What is the significance of the MaxHealth acquisition?

    The acquisition of MaxHealth on February 13, 2026, for approximately $908 million, is a strategic move to enhance Humana's primary care capabilities. It contributed significantly to the increase in goodwill and other intangible assets on the balance sheet and is expected to support the company's integrated care delivery model.

  4. How has the company's net income performed year-over-year for the first nine months of 2026?

    Humana reported net income attributable to Humana of $2.04 billion for the nine months ended September 30, 2026, a slight increase from $1.98 billion in the same period of the prior year. This stability in net income, despite increased benefit costs, demonstrates effective cost management and operational efficiencies.